Krisztina M. Zsebo - 14 Apr 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
14 Apr 2022
Net transactions value
$0
Form type
4
Filing time
12 May 2023, 20:21:34 UTC
Previous filing
15 Jun 2021
Next filing
30 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Stock Option (right to buy) Award $0 +31,085 +125% $0.000000 55,953 14 Apr 2022 Common stock 31,085 $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to one-third of the shares on December 22, 2021 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

This Form 4 is late due to an inadvertent administrative error.